Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-08-08
2010-12-14
Rawlings, Stephen L (Department: 1643)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S254100, C530S324000, C530S350000, C536S023500
Reexamination Certificate
active
07851181
ABSTRACT:
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
REFERENCES:
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5198340 (1993-03-01), Mukku
patent: 5262308 (1993-11-01), Baserga
patent: 5385839 (1995-01-01), Stinski
patent: 5545403 (1996-08-01), Page
patent: 5545404 (1996-08-01), Page
patent: 5545405 (1996-08-01), Page
patent: 5849522 (1998-12-01), Fleckenstein et al.
patent: 5942412 (1999-08-01), Prager et al.
patent: 5958872 (1999-09-01), O'Connor et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 6084085 (2000-07-01), Baserga et al.
patent: 6218140 (2001-04-01), Fleckenstein et al.
patent: 6294330 (2001-09-01), Michnick et al.
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 6316462 (2001-11-01), Bishop et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6346390 (2002-02-01), Olsson et al.
patent: 6372250 (2002-04-01), Pardridge
patent: 6537988 (2003-03-01), Lee
patent: 6645775 (2003-11-01), Clark et al.
patent: 7037498 (2006-05-01), Cohen et al.
patent: 7217796 (2007-05-01), Wang et al.
patent: 2002/0022023 (2002-02-01), Ullrich et al.
patent: 2002/0025313 (2002-02-01), Micklus et al.
patent: 2002/0107187 (2002-08-01), Kingston et al.
patent: 2002/0132275 (2002-09-01), Fidler et al.
patent: 2002/0155095 (2002-10-01), Nagabhushan et al.
patent: 2002/0164333 (2002-11-01), Nemerow et al.
patent: 2002/0169116 (2002-11-01), Kingston et al.
patent: 2002/0187925 (2002-12-01), Kingston et al.
patent: 2002/0197262 (2002-12-01), Hasan et al.
patent: 2003/0021780 (2003-01-01), Smith et al.
patent: 2003/0031658 (2003-02-01), Brodt et al.
patent: 2003/0045676 (2003-03-01), Kingston et al.
patent: 2003/0088061 (2003-05-01), Staunton
patent: 2003/0092631 (2003-05-01), Deshayes et al.
patent: 2003/0138430 (2003-07-01), Stimmel et al.
patent: 2003/0165502 (2003-09-01), Fujita-Yamaguchi
patent: 2003/0195147 (2003-10-01), Pillutla et al.
patent: 2003/0235582 (2003-12-01), Singh et al.
patent: 2003/0236190 (2003-12-01), Pillutla et al.
patent: 2004/0009154 (2004-01-01), Khan et al.
patent: 2004/0009906 (2004-01-01), Kakkis et al.
patent: 2004/0018191 (2004-01-01), Wang et al.
patent: 2004/0023887 (2004-02-01), Pillutla et al.
patent: 2004/0047835 (2004-03-01), Bianco
patent: 2004/0057950 (2004-03-01), Waksal et al.
patent: 2004/0086503 (2004-05-01), Cohen et al.
patent: 2004/0086511 (2004-05-01), Zack et al.
patent: 2004/0102360 (2004-05-01), Barnett et al.
patent: 2004/0116330 (2004-06-01), Naito et al.
patent: 2004/0142381 (2004-07-01), Hubbard et al.
patent: 2004/0202651 (2004-10-01), Cohen et al.
patent: 2004/0228857 (2004-11-01), Page et al.
patent: 2004/0228859 (2004-11-01), Graus et al.
patent: 2004/0265307 (2004-12-01), Singh et al.
patent: 2005/0008642 (2005-01-01), Graus et al.
patent: 2005/0048050 (2005-03-01), Fujita-Yamaguchi
patent: 2005/0069539 (2005-03-01), Cohen et al.
patent: 2005/0084906 (2005-04-01), Goetsch et al.
patent: 2005/0169933 (2005-08-01), Steeves et al.
patent: 2005/0186203 (2005-08-01), Singh et al.
patent: 2005/0244408 (2005-11-01), Cohen et al.
patent: 2005/0249728 (2005-11-01), Singh et al.
patent: 2005/0249730 (2005-11-01), Goetsch et al.
patent: 2005/0272637 (2005-12-01), Clinton et al.
patent: 2005/0272755 (2005-12-01), Denis et al.
patent: 2005/0281812 (2005-12-01), Cohen et al.
patent: 2006/0018910 (2006-01-01), Gualberto et al.
patent: 2006/0233804 (2006-10-01), Deshayes et al.
patent: 2006/0233814 (2006-10-01), Goldmakher
patent: 2008/0279852 (2008-11-01), Page et al.
patent: 197 19 001 (2001-05-01), None
patent: 0481790 (1992-04-01), None
patent: 1484402 (2004-12-01), None
patent: 1950301 (2008-07-01), None
patent: 2834900 (2003-07-01), None
patent: 2834990 (2003-07-01), None
patent: 2834991 (2003-07-01), None
patent: WO 91/04014 (1991-04-01), None
patent: WO 91/14438 (1991-10-01), None
patent: WO 97/44352 (1997-11-01), None
patent: WO98/17801 (1998-04-01), None
patent: WO 98/22092 (1998-05-01), None
patent: WO 98/45427 (1998-10-01), None
patent: WO 99/25378 (1999-05-01), None
patent: WO 99/28347 (1999-06-01), None
patent: WO 99/42127 (1999-08-01), None
patent: WO 99/60023 (1999-11-01), None
patent: WO 00/22130 (2000-04-01), None
patent: WO 00/50067 (2000-08-01), None
patent: WO 00/69454 (2000-11-01), None
patent: WO 00/69454 (2000-11-01), None
patent: WO 01/07084 (2001-02-01), None
patent: WO 01/30964 (2001-05-01), None
patent: WO 01/36632 (2001-05-01), None
patent: WO 01/70268 (2001-09-01), None
patent: WO 01/70930 (2001-09-01), None
patent: WO 01/72771 (2001-10-01), None
patent: WO 01/75064 (2001-10-01), None
patent: WO 02/04522 (2002-01-01), None
patent: WO 02/07783 (2002-01-01), None
patent: WO 02/27017 (2002-04-01), None
patent: WO 02/31500 (2002-04-01), None
patent: WO 02/43758 (2002-06-01), None
patent: WO 02/053596 (2002-07-01), None
patent: WO 02/054066 (2002-07-01), None
patent: WO 02/072780 (2002-09-01), None
patent: WO 2004/087756 (2002-10-01), None
patent: WO 02/088752 (2002-11-01), None
patent: WO 02/092599 (2002-11-01), None
patent: WO 02/102854 (2002-12-01), None
patent: WO 02/102972 (2002-12-01), None
patent: WO 02/102973 (2002-12-01), None
patent: WO 03/000928 (2003-01-01), None
patent: WO 03/014696 (2003-02-01), None
patent: WO 03/027246 (2003-04-01), None
patent: WO 03/039538 (2003-05-01), None
patent: WO 03/059951 (2003-07-01), None
patent: WO 03/088910 (2003-10-01), None
patent: WO03/100059 (2003-12-01), None
patent: WO 03/106621 (2003-12-01), None
patent: WO 2004/030625 (2004-04-01), None
patent: WO 2004/030627 (2004-04-01), None
patent: WO 2004/056865 (2004-07-01), None
patent: WO 2004/071529 (2004-08-01), None
patent: WO 2004/083248 (2004-09-01), None
patent: WO2004/096224 (2004-11-01), None
patent: WO 2005/005635 (2005-01-01), None
patent: WO 2005/016967 (2005-02-01), None
patent: WO 2005/016970 (2005-02-01), None
patent: WO 2005/016970 (2005-02-01), None
patent: WO 2005/061541 (2005-07-01), None
patent: WO2005/117980 (2005-12-01), None
patent: WO2006/013472 (2006-02-01), None
patent: WO2006/020258 (2006-02-01), None
patent: WO 2006/069202 (2006-06-01), None
Green, Larry L.; “Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies”; Journal of Immunological Methods; 231:11-23 (1999).
Stefania Benini et al., Inhibition of Insulin-like Growth Factor I Receptor Increases the Antitumor Activity of Doxorubicin and Vincristine Against Ewing's Sarcoma Cells, Clinical Cancer Research, vol. 7, '1790-1797, Jun. 2001.
V.M. Macaulay, Insulin-like Growth Factors and Cancer, Br. J. Cancer, 65, 311-320, 1992.
Xiangdang Liu et al., Inhibition of Insulin-like Growth Factor I Receptor Expression in Neuroblastoma Cells Induces the Regression of Established Tumors in Mice, Cancer Research 58, 5432-5438, Dec. 1, 1998.
Jamie L. Resnik et al., Elevated Insulin-like Growth Factor I Receptor Autophosphorylation and Kinase Activity in Human Breast Cancer, Cancer Research 58, 1159-1164, Mar. 15, 1998.
Fredrika Pekonen et al., Receptors for Epidermal Growth Factor and Insulin-like Growth Factor I and Their Relation to Steroid Receptors in Human Breast Cancer, Cancer Research 48, 1343-1347, Mar. 1, 1988.
Quynh T. Rohlik et al., An Antibody to the Receptor for Insulin-like Growth Factor I Inhibits the Growth of MCF-7 Cells in Tissue Culture, Biochemical and Biophysical Research Communications, vol. 149, No. 1, 276-281, 1987.
Carlos L. Arteaga et al., Blockade of the Type I Somatomedin Receptor Inhibits Growth of Human Breast Cancer Cells in Athymic Mice, J. Clin. Invest., vol. 84, 1418-1423, Nov. 1989.
Ted Gansler et al., Rapid Communication Antibody to Type I Insulinlike Growth Factor Receptor Inh
Brams Peter
Feingersh Diane
Greenberg Robert
Hailey Judith
Pachter Jonathan A.
Rawlings Stephen L
Schering Corporation
LandOfFree
Neutralizing human anti-IGFR antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutralizing human anti-IGFR antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing human anti-IGFR antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4214627